ADC Therapeutics
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Biopôle 3b, Epalinges, Vaud, 1066, Switz...Phone Number
+41 216530200Website
www.adctherapeutics.comRevenue
$79.2 MillionStock Symbol
ADCTIndustry
ZI Rank: 1
About ADC Therapeutics
ADC Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ADC Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ADC Therapeutics recently announced quarterly report
Product Launch: Get notified when ADC Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check if ADC Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if ADC Therapeutics had a recent Job posting/layoffs
Check out if ADC Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ADC Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ADC Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ADC Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined ADC Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
ADC Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ADC Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ADC Therapeutics.
ADC Therapeutics financials insights
Gather financial insights about ADC Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$40M
Unspecified
$80M
Share Placement
$105M
Series D
$105M
Series E
$303M
Stock Offering
$267.6M
Private Equity
$6.3M
Debt
$175M
Stock/Share Issuance
$100M
ADC Therapeutics Tech Stack
A closer look at the technologies used by ADC Therapeutics
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding ADC Therapeutics
ADC Therapeutics SA is a publicly traded, commercial-stage oncology biotechnology company headquartered in Epalinges, Switzerland, and listed on the NYSE under the ticker ADCT. Founded in 2011, the company is a global pioneer in the development of next-generation antibody drug conjugates (ADCs) for the treatment of hematologic malignancies and soli... Read More
